menu
    • menu

    Company profile for NeuroBo Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeuroBo is a clinical-stage biopharmaceutical company with two drug programs that hope to impact a range of indications in neurodegenerative disease. NeuroBo Pharmaceuticals is addressing unmet needs in patients with diabetic neuropathy and Alzheimer’s disease. Our Phase III-ready drug, NB-01, is based on natural sources and has shown successful Phase II results with excellent efficacy and safety in diabetic neuropathic pain...
    NeuroBo is a clinical-stage biopharmaceutical company with two drug programs that hope to impact a range of indications in neurodegenerative disease. NeuroBo Pharmaceuticals is addressing unmet needs in patients with diabetic neuropathy and Alzheimer’s disease. Our Phase III-ready drug, NB-01, is based on natural sources and has shown successful Phase II results with excellent efficacy and safety in diabetic neuropathic pain (DNP) and we have strong preclinical data in both neuropathic pain and diabetes models showing a mode of action of NB-01 on nerve growth factor (NGF) release for nerve stabilization and regeneration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroBo PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    177 Huntington Avenue Suite 1700 Boston, MA 02115
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurobopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurobo-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NeuroBo Pharmaceuticals rebrands to become MetaVia
    NeuroBo Pharmaceuticals rebrands to become MetaVia

    19 Nov 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/neurobo-pharmaceuticals-rebrands-become-metavia

    FIERCE PHARMA
    19 Nov 2024
    Share Share
    NeuroBo Reports Positive Data From DA-1726 Trial For Obesity
    NeuroBo Reports Positive Data From DA-1726 Trial For Obesity

    30 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-positive-top-line-data-from-the-sad-part-1-of-its-phase-1-clinical-trial-evaluating-da-1726-for-the-treatment-of-obesity-302261698.html

    PR NEWSWIRE
    30 Sep 2024
    Share Share
    NeuroBo to Participate in H.C. Wainwright Global Investment Conference
    NeuroBo to Participate in H.C. Wainwright Global Investment Conference

    03 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurobo-to-participate-in-the-hc-wainwright-26th-annual-global-investment-conference-302236111.html

    PR NEWSWIRE
    03 Sep 2024
    Share Share
    NeuroBo Reports Q2 2024 Results And Provides Corporate Update
    NeuroBo Reports Q2 2024 Results And Provides Corporate Update

    14 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-reports-second-quarter-2024-financial-results-and-provides-corporate-update-302222264.html

    PR NEWSWIRE
    14 Aug 2024
    Share Share
    NeuroBo Signs Exclusive License Agreement with MTHERA for NB-01
    NeuroBo Signs Exclusive License Agreement with MTHERA for NB-01

    30 Jul 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-07-30/neurobo-signs-exclusive-license-agreement-with-mthera-for-nb-01/9769

    CONTRACT PHARMA
    30 Jul 2024
    Share Share
    NeuroBo Closes Up to $70M Concurrent Private Placement and Registered Offering
    NeuroBo Closes Up to $70M Concurrent Private Placement and Registered Offering

    25 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-the-closing-of-up-to-70-million-concurrent-private-placement-and-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-302182326.html

    PR NEWSWIRE
    25 Jun 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search